Company profile: Horizon Discovery
1.1 - Company Overview
Company description
- Provider of gene editing and gene modulation platforms and services, including the Pin-point Base Editing Platform for precise base changes, Dharmacon siRNA, shRNA, and CRISPR reagents, drug discovery screening services, pre-engineered cell lines, and Mimix cell line-derived molecular reference standards for research and clinical applications.
Products and services
- Dharmacon Reagents: Supplies functional genomic tools—siRNA, shRNA, and CRISPR components—for gene modulation and editing across applications, modular
- Pin-point Base Editing Platform: Architects precise base changes within genomic DNA to enable gene silencing, correction of defined mutations, and optimization of cell therapy characteristics, precision-engineered
- Screening Services: Offers drug discovery and development using cell panel screening, functional genomic screening, and immune cell screening across programs, panel-based
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Horizon Discovery
Azitra
HQ: United States
Website
- Description: Provider of microbiome-based dermatology therapeutics and consumer products, offering bioengineered live biotherapeutic candidates ATR-12 for Netherton syndrome, ATR-04 for EGFR inhibitor-associated rash, and protein candidate ATR-01 for ichthyosis vulgaris; and a microbiome dermatology platform to develop products for skin disease treatment and skin appearance improvement; plus topical ointments and creams for dryness, redness, flakiness, and inflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Azitra company profile →
Lysogene
HQ: France
Website
- Description: Provider of basic research and clinical development of gene therapy for neurodegenerative disorders, developing AAV vectors, with a mission to improve the health of patients with incurable, life-threatening conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lysogene company profile →
SolveBio
HQ: United States
Website
- Description: Provider of a Genomic Intelligence Platform and on-demand expertise that monitors, gathers, and secures genomic data to drive precision medicine, serving pharma, biotech, and diagnostic organizations with a contextual knowledge hub to connect and use external and internal genomic information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SolveBio company profile →
Toyobo
HQ: United States
Website
- Description: Provider of life science products in Japan for research and industrial fields, including KOD DNA Polymerase with proofreading/high elongation for PCR; ReverTra Ace M-MLV reverse transcriptase for efficient cDNA synthesis; MagExtractor kits with magnetic silica beads for nucleic acid extraction; THUNDERBIRD qPCR mix for SYBR Green I; GenNext NGS library prep for Illumina; and one-step RT-PCR Quick Master Mix using Tth DNA polymerase.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Toyobo company profile →
Decipher Bio
HQ: United States
Website
- Description: Provider of genomic tests for urological cancers, including Decipher Prostate for risk scores to guide treatment decisions and Decipher Bladder for molecular subtyping to aid planning, and the Decipher GRID research platform of whole-transcriptome profiles. Continues to build its GRID database and partners with pharmaceutical companies to identify biomarkers of response to novel therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Decipher Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Horizon Discovery
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Horizon Discovery
2.2 - Growth funds investing in similar companies to Horizon Discovery
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Horizon Discovery
4.2 - Public trading comparable groups for Horizon Discovery
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →